The impact of a multidisciplinary blood conservation protocol on patient outcomes and cost after cardiac surgery. (abre una nueva ventana)

Ad N, Holmes SD, Patel J, Shuman DJ, Massimiano PS, Choi E, Fitzgerald D, Halpin L, Fornaresio LM.

Fuente‎: J Thorac Cardiovasc Surg 2017;153(3):597-605.e1.

Indexado en‎: PubMed 27938898

DOI‎: 10.1016/j.jtcvs.2016.10.083

https://www.ncbi.nlm.nih.gov/pubmed/27938898 (abre una nueva ventana)

Costs of bleeds relating to acute coronary syndrome therapies. (abre una nueva ventana)

Bufe A, Emile F, Drogoul L, Guindo Soldevila J, Giuseppe DP, Maddalena L, Janzon M, Brown RE.

Fuente‎: J Med Econ 2010;13(2):236-40.

Indexado en‎: PubMed 20465368

DOI‎: 10.3111/13696998.2010.488882

https://www.ncbi.nlm.nih.gov/pubmed/20465368 (abre una nueva ventana)

Preoperative anemia management program reduces blood transfusion in elective cardiac surgical patients, improving outcomes and decreasing hospital length of stay. (abre una nueva ventana)

Cahill CM, Alhasson B, Blumberg N, Melvin A, Knight P, Gloff M, Robinson R, Akwaa F, Refaai MA.

Fuente‎: Transfusion 2021;61(9):2629-36.

Indexado en‎: PubMed 34268778

DOI‎: 10.1111/trf.16564

https://www.ncbi.nlm.nih.gov/pubmed/34268778 (abre una nueva ventana)

Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery. (abre una nueva ventana)

Chapman AJ, Blount AL, Davis AT, Hooker RL.

Fuente‎: Eur J Cardiothorac Surg 2011;40(6):1314-8.

Indexado en‎: PubMed 21601468

DOI‎: 10.1016/j.ejcts.2011.03.048

https://www.ncbi.nlm.nih.gov/pubmed/21601468 (abre una nueva ventana)

Experience of a network of transfusion coordinators for blood conservation (Ontario Transfusion Coordinators [ONTraC]). (abre una nueva ventana)

Freedman J, Luke K, Escobar M, Vernich L, Chiavetta JA.

Fuente‎: Transfusion 2008;48(2):237-50.

Indexado en‎: PubMed 18005329

DOI‎: 10.1111/j.1537-2995.2007.01515.x

https://www.ncbi.nlm.nih.gov/pubmed/18005329 (abre una nueva ventana)

Clinical effects of reverting from leukoreduced to nonleukoreduced blood in cardiac surgery. (abre una nueva ventana)

Fung MK, Moore K, Ridenour M, Mook W, Triulzi DJ.

Fuente‎: Transfusion 2006;46(3):386-91.

Indexado en‎: PubMed 16533280

DOI‎: 10.1111/j.1537-2995.2006.00733.x

https://www.ncbi.nlm.nih.gov/pubmed/16533280 (abre una nueva ventana)

Clinical and economic outcomes associated with blood transfusions among elderly Americans following coronary artery bypass graft surgery requiring cardiopulmonary bypass. (abre una nueva ventana)

Ganz ML, Wu N, Rawn J, Pashos CL, Strandberg-Larsen M.

Fuente‎: Blood Transfus 2014;12 Suppl 1:s90-9.

Indexado en‎: PubMed 23399371

DOI‎: 10.2450/2013.0170-12

https://www.ncbi.nlm.nih.gov/pubmed/23399371 (abre una nueva ventana)

Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven®): a propensity score analysis. (abre una nueva ventana)

Gelsomino S, Lorusso R, Romagnoli S, Bevilacqua S, De Cicco G, Billè G, Stefàno P, Gensini GF.

Fuente‎: Eur J Cardiothorac Surg 2008;33(1):64-71.

Indexado en‎: PubMed 17996457

DOI‎: 10.1016/j.ejcts.2007.10.004

https://www.ncbi.nlm.nih.gov/pubmed/17996457 (abre una nueva ventana)

The clinical and economic burden of significant bleeding during lung resection surgery: a retrospective matched cohort analysis of real-world data. (abre una nueva ventana)

Ghosh SK, Roy S, Daskiran M, Yoo A, Li G, Fegelman EJ.

Fuente‎: J Med Econ 2016;19(11):1081-6.

Indexado en‎: PubMed 27266753

DOI‎: 10.1080/13696998.2016.1199431

https://www.ncbi.nlm.nih.gov/pubmed/27266753 (abre una nueva ventana)

How do we develop and implement a preoperative anemia clinic designed to improve perioperative outcomes and reduce cost? (abre una nueva ventana)

Guinn NR, Guercio JR, Hopkins TJ, Grimsley A, Kurian DJ, Jimenez MI, Bolognesi MP, Schroeder R, Aronson S; Duke Perioperative Enhancement Team (POET).

Fuente‎: Transfusion 2016;56(2):297-303.

Indexado en‎: PubMed 26592207

DOI‎: 10.1111/trf.13426

https://www.ncbi.nlm.nih.gov/pubmed/26592207 (abre una nueva ventana)

Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. (abre una nueva ventana)

Helm RE, Rosengart TK, Gomez M, Klemperer JD, DeBois WJ, Velasco F, Gold JP, Altorki NK, Lang S, Thomas S, Isom OW, Krieger KH.

Fuente‎: Ann Thorac Surg 1998;65(1):125-36.

Indexado en‎: PubMed 9456106

https://www.ncbi.nlm.nih.gov/pubmed/9456106 (abre una nueva ventana)

Positive impact of retrograde autologous priming in adult patients undergoing cardiac surgery: a randomized clinical trial. (abre una nueva ventana)

Hofmann B, Kaufmann C, Stiller M, Neitzel T, Wienke A, Silber RE, Treede H.

Fuente‎: J Cardiothorac Surg 2018;13(1):50.

Indexado en‎: PubMed 29784004

DOI‎: 10.1186/s13019-018-0739-0

https://www.ncbi.nlm.nih.gov/pubmed/29784004 (abre una nueva ventana)

Cost effectiveness of implementing ESC guidelines for treatment of iron deficiency in heart failure in the Nordic countries. (abre una nueva ventana)

Hofmarcher T, Cabrales Alin D, Linde C.

Fuente‎: Scand Cardiovasc J 2018;52(6):348-55.

Indexado en‎: PubMed 30457358

DOI‎: 10.1080/14017431.2018.1546894

https://www.ncbi.nlm.nih.gov/pubmed/30457358 (abre una nueva ventana)

Economic evaluation of national patient blood management clinical guidelines in cardiac surgery. (abre una nueva ventana)

Irving AH, Harris A, Petrie D, Higgins A, Smith JA, Tran L, Reid CM, McQuilten ZK.

Fuente‎: Value Health 2022;25(3):419-26.

Indexado en‎: PubMed 35227454

DOI‎: 10.1016/j.jval.2021.07.014

https://www.ncbi.nlm.nih.gov/pubmed/35227454 (abre una nueva ventana)

Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. (abre una nueva ventana)

LaPar DJ, Crosby IK, Ailawadi G, Ad N, Choi E, Spiess BD, Rich JB, Kasirajan V, Fonner E Jr, Kron IL, Speir AM; Investigators for the Virginia Cardiac Surgery Quality Initiative.

Fuente‎: J Thorac Cardiovasc Surg 2013;145(3):796-804.

Indexado en‎: PubMed 23414992

DOI‎: 10.1016/j.jtcvs.2012.12.041

https://www.ncbi.nlm.nih.gov/pubmed/23414992 (abre una nueva ventana)

Intraoperative cell salvage versus allogeneic transfusion during abdominal aortic surgery: clinical and financial outcomes. (abre una nueva ventana)

Marković M, Davidović L, Savić N, Sindjelić R, Ille T, Dragas M.

Fuente‎: Vascular 2009;17(2):83-92.

Indexado en‎: PubMed 19426638

DOI‎: 10.2310/6670.2009.00009

https://www.ncbi.nlm.nih.gov/pubmed/19426638 (abre una nueva ventana)

Evaluation of a multilevel laboratory stewardship intervention targeted to cardiac and thoracic surgical services at an academic medical center. (abre una nueva ventana)

Mathias PC, Khor S, Harris K, Wood SJ, Farjah F.

Fuente‎: Arch Pathol Lab Med 2023;147(8):957-63.

Indexado en‎: PubMed 36287195

DOI‎: doi: 10.5858/arpa.2021-0593-OA.

https://www.ncbi.nlm.nih.gov/pubmed/36287195 (abre una nueva ventana)

Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. (abre una nueva ventana)

Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD.

Fuente‎: Circulation 2007;116(22):2544-52.

Indexado en‎: PubMed 17998460

DOI‎: 10.1161/CIRCULATIONAHA.107.698977

https://www.ncbi.nlm.nih.gov/pubmed/17998460 (abre una nueva ventana)

Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion after off-pump coronary artery bypass surgery: A randomized trial. (abre una nueva ventana)

Murphy GJ, Rogers CS, Lansdowne WB, Channon I, Alwair H, Cohen A, Caputo M, Angelini GD.

Fuente‎: J Thorac Cardiovasc Surg 2005;130(1):20-8.

Indexado en‎: PubMed 15999036

DOI‎: 10.1016/j.jtcvs.2004.12.006

https://www.ncbi.nlm.nih.gov/pubmed/15999036 (abre una nueva ventana)

Bleeding after cardiac surgery is associated with an increase in the total cost of the hospital stay. (abre una nueva ventana)

Newcomb AE, Dignan R, McElduff P, Pearse EJ, Bannon P.

Fuente‎: Ann Thorac Surg 2020;109(4):1069-78.

Indexado en‎: PubMed 31904370

DOI‎: 10.1016/j.athoracsur.2019.11.019

https://www.ncbi.nlm.nih.gov/pubmed/31904370 (abre una nueva ventana)

Protocol guided bleeding management improves cardiac surgery patient outcomes. (abre una nueva ventana)

Pearse BL, Smith I, Faulke D, Wall D, Fraser JF, Ryan EG, Drake L, Rapchuk IL, Tesar P, Ziegenfuss M, Fung YL.

Fuente‎: Vox Sang 2015;109(3):267-79.

Indexado en‎: PubMed 25930098

DOI‎: 10.1111/vox.12279

https://www.ncbi.nlm.nih.gov/pubmed/25930098 (abre una nueva ventana)

Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. (abre una nueva ventana)

Rao SV, Kaul PR, Liao L, Armstrong PW, Ohman EM, Granger CB, Califf RM, Harrington RA, Eisenstein EL, Mark DB.

Fuente‎: Am Heart J 2008;155(2):369-74.

Indexado en‎: PubMed 18215610

DOI‎: 10.1016/j.ahj.2007.10.014

https://www.ncbi.nlm.nih.gov/pubmed/18215610 (abre una nueva ventana)

Mortality, length of stay, and cost implications of procedural bleeding after percutaneous interventions using large-bore catheters. (abre una nueva ventana)

Redfors B, Watson BM, McAndrew T, Palisaitis E, Francese DP, Razavi M, Safirstein J, Mehran R, Kirtane AJ, Généreux P.

Fuente‎: JAMA Cardiol 2017;2(7):798-802.

Indexado en‎: PubMed 28315573

DOI‎: 10.1001/jamacardio.2017.0265

https://www.ncbi.nlm.nih.gov/pubmed/28315573 (abre una nueva ventana)

Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery. (abre una nueva ventana)

Scott BH, Seifert FC, Grimson R.

Fuente‎: Ann Card Anaesth 2008;11(1):15-9.

Indexado en‎: PubMed 18182754

https://www.ncbi.nlm.nih.gov/pubmed/18182754 (abre una nueva ventana)

Hospital economic impact from hemostatic matrix usage in cardiac surgery. (abre una nueva ventana)

Tackett SM, Sugarman R, Kreuwel HT, Alvarez P, Nasso G.

Fuente‎: J Med Econ 2014;17(9):670-6.

Indexado en‎: PubMed 24927164

DOI‎: 10.3111/13696998.2014.928638

https://www.ncbi.nlm.nih.gov/pubmed/24927164 (abre una nueva ventana)

A structured blood conservation programme reduces transfusions and costs in cardiac surgery. (abre una nueva ventana)

Ternström L, Hyllner M, Backlund E, Schersten H, Jeppsson A.

Fuente‎: Interact Cardiovasc Thorac Surg 2014;19(5):788-94.

Indexado en‎: PubMed 25125140

DOI‎: 10.1093/icvts/ivu266

https://www.ncbi.nlm.nih.gov/pubmed/25125140 (abre una nueva ventana)

Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes. (abre una nueva ventana)

Uber WE, Toole JM, Stroud MR, Haney JS, Lazarchick J, Crawford FA Jr, Ikonomidis JS.

Fuente‎: J Thorac Cardiovasc Surg 2011;141(6):1469-77.e2.

Indexado en‎: PubMed 21457998

DOI‎: 10.1016/j.jtcvs.2011.02.033

https://www.ncbi.nlm.nih.gov/pubmed/21457998 (abre una nueva ventana)

Safety, efficacy, and cost-effectiveness of intraoperative blood salvage in OPCABG with different amount of bleeding: a single-center, retrospective study. (abre una nueva ventana)

Wang H, Zheng W, Fang W, Meng G, Zhang L, Zhou Y, Gu E, Liu X.

Fuente‎: J Cardiothorac Surg 2018;13(1):109.

Indexado en‎: PubMed 30333028

DOI‎: 10.1186/s13019-018-0794-6

https://www.ncbi.nlm.nih.gov/pubmed/30333028 (abre una nueva ventana)

Management of blood transfusion in aortic valve surgery: impact of a blood conservation strategy. (abre una nueva ventana)

Yaffee DW, Smith DE 3rd, Ursomanno PA, Hill FT, Galloway AC, Deanda A, Grossi EA.

Fuente‎: Ann Thorac Surg 2014;97(1):95-101.

Indexado en‎: PubMed 24263014

DOI‎: 10.1016/j.athoracsur.2013.09.057

https://www.ncbi.nlm.nih.gov/pubmed/24263014 (abre una nueva ventana)

Cost of bleeding in trauma and complex cardiac surgery. (abre una nueva ventana)

Zbrozek A, Magee G.

Fuente‎: Clin Ther 2015;37(9):1966-74.

Indexado en‎: PubMed 26210074

DOI‎: 10.1016/j.clinthera.2015.06.007

https://www.ncbi.nlm.nih.gov/pubmed/26210074 (abre una nueva ventana)